A detailed history of Tokio Marine Asset Management CO LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 46,122 shares of LLY stock, worth $35.4 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
46,122
Previous 44,677 3.23%
Holding current value
$35.4 Million
Previous $40.4 Million 1.02%
% of portfolio
1.81%
Previous 1.95%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $1.12 Million - $1.39 Million
1,445 Added 3.23%
46,122 $40.9 Million
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $267,477 - $335,435
369 Added 0.83%
44,677 $40.4 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $2.07 Million - $2.77 Million
-3,501 Reduced 7.32%
44,308 $34.5 Million
Q4 2023

Feb 02, 2024

BUY
$525.19 - $619.13 $298,307 - $351,665
568 Added 1.2%
47,809 $27.9 Million
Q3 2023

Nov 02, 2023

SELL
$434.7 - $599.3 $325,590 - $448,875
-749 Reduced 1.56%
47,241 $25.4 Million
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $724,628 - $968,912
2,066 Added 4.5%
47,990 $22.5 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $10.1 Million - $11.9 Million
32,502 Added 242.15%
45,924 $15.8 Million
Q4 2022

Jan 26, 2023

BUY
$321.55 - $374.67 $441,488 - $514,421
1,373 Added 11.4%
13,422 $0
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $378,604 - $431,459
1,277 Added 11.85%
12,049 $3.9 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $511,748 - $600,867
1,836 Added 20.55%
10,772 $3.49 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $259,801 - $322,867
-1,107 Reduced 11.02%
8,936 $2.56 Million
Q4 2021

Jan 26, 2022

BUY
$224.85 - $279.04 $51,490 - $63,900
229 Added 2.33%
10,043 $2.77 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $107,032 - $131,718
483 Added 5.18%
9,814 $2.27 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $27,804 - $35,965
-154 Reduced 1.62%
9,331 $2.14 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $660,895 - $855,559
4,022 Added 73.62%
9,485 $1.77 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $55,315 - $73,195
424 Added 8.41%
5,463 $922,000
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $85,246 - $98,602
583 Added 13.08%
5,039 $746,000
Q2 2020

Aug 07, 2020

BUY
$136.42 - $164.18 $78,714 - $94,731
577 Added 14.87%
4,456 $732,000
Q1 2020

May 12, 2020

SELL
$119.05 - $147.35 $82,263 - $101,818
-691 Reduced 15.12%
3,879 $538,000
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $30,472 - $37,742
285 Added 6.65%
4,570 $601,000
Q3 2019

Oct 29, 2019

BUY
$106.79 - $116.16 $24,882 - $27,065
233 Added 5.75%
4,285 $479,000
Q2 2019

Jul 25, 2019

BUY
$110.79 - $129.32 $56,170 - $65,565
507 Added 14.3%
4,052 $449,000
Q1 2019

Apr 25, 2019

SELL
$111.31 - $131.02 $188,336 - $221,685
-1,692 Reduced 32.31%
3,545 $460,000
Q4 2018

Feb 04, 2019

SELL
$105.9 - $118.64 $22,027 - $24,677
-208 Reduced 3.82%
5,237 $606,000
Q3 2018

Oct 23, 2018

SELL
$85.86 - $107.31 $105,178 - $131,454
-1,225 Reduced 18.37%
5,445 $584,000
Q2 2018

Jul 18, 2018

SELL
$75.7 - $86.88 $706,962 - $811,372
-9,339 Reduced 58.34%
6,670 $569,000
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $3.81 Million - $4.5 Million
-51,377 Reduced 76.24%
16,009 $1.24 Million
Q4 2017

Feb 05, 2018

SELL
$81.94 - $87.89 $155,604 - $166,903
-1,899 Reduced 2.74%
67,386 $5.69 Million
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $434,135 - $481,846
5,633 Added 8.85%
69,285 $5.93 Million
Q2 2017

Jan 11, 2018

BUY
N/A
7,051 Added 12.46%
63,652 $5.24 Million
Q1 2017

Jan 11, 2018

SELL
N/A
-17,167 Reduced 23.27%
56,601 $4.76 Million
Q4 2016

Jan 11, 2018

SELL
N/A
-11,667 Reduced 13.66%
73,768 $5.43 Million
Q3 2016

Jan 11, 2018

SELL
N/A
-6,260 Reduced 6.83%
85,435 $6.86 Million
Q2 2016

Jan 11, 2018

BUY
N/A
829 Added 0.91%
91,695 $7.22 Million
Q1 2016

Jan 11, 2018

BUY
N/A
90,866
90,866 $6.54 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.